Fig. 1: Flow diagram of patients included from the COVID-CNS. | Nature Medicine

Fig. 1: Flow diagram of patients included from the COVID-CNS.

From: Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

Fig. 1: Flow diagram of patients included from the COVID-CNS.

Nationally at least 16,279 patients were screened of whom at least 2,712 were eligible. Matched community data were collected separately and held in a large normative database. ‘Other’ includes autonomic dysfunction3, cerebral hypoxic injury2, headache6, headache and fatigue2, hyperkinetic movement disorder2, Parkinsonian movement disorder2, seizures7 and speech and sensory1. aSix patients with ‘anosmia/ageusia’ reclassified as COVID from NeuroCOVID. The parentheses show n with biomarkers, n with neuroimaging. MOCA, Montreal Cognitive Assessment.

Back to article page